Avrupa’da ilaç lansmanları Trump’ın fiyatlandırma emrinden sonra %27 düştü

21 kaynak
wsj.com
  • GlobalData analizi, Avrupa'nın referans pazarlarında yeni marka ilaç lansmanlarının, Trump'ın MFN emrinden sonraki 17 ayda %27 azaldığını ortaya koydu.
  • The Wall Street Journal, Avrupa'daki onayların sabit kaldığını, ancak Amgen'in Danimarka'dan bir kolesterol ilacını çektiğini ve Insmed'in lansmanları ertelediğini bildirdi.
  • pharmaphorum ve STAT'a göre, AbbVie ve Bristol Myers Squibb yurt dışında ABD seviyesinde fiyatlar planlıyor ve Kongre'deki Demokratlar MFN anlaşmalarını soruşturmak için harekete geçiyor.
Kaynaklar (21)
  1. 1 Single-source drug launches in GLOBE/GUARD European ... www.globaldata.com
  2. 2 Trump’s Plan to Lower Drug Prices in U.S. Is Leading to Fewer New Drugs in Europe www.wsj.com
  3. 3 European drug launches drop 27% amid Trump's pricing ... www.emarketer.com
  4. 4 FT Summit: How Is U.S. Policy Reshaping the UK and EU Pharma ... pharmaphorum.com
  5. 5 Pharmalittle: We're reading about Dems eyeing Trump MFN deals, fewer drug launches in Europe, and more www.statnews.com
  6. 6 Most-favored nations policy makes drugmakers rethink launches abroad www.statnews.com
  7. 7 Most-Favoured-Nation Drug Pricing: The Complete Report (Version 1 mirkovonhein.com
  8. 8 美 약값 낮추려다 유럽 신약 출시 27% 급감…트럼프 정책 역풍 www.hankyung.com
  9. 9 One year after MFN: How US policy is reshaping the global ... pharmaphorum.com
  10. 10 Trump, European drug prices and the payoff for new medicines www.drugdiscoverytrends.com
  11. 11 MFN drug pricing: GLOBE, GUARD and EU launches | Evidaxia www.evidaxia.com
  12. 12 How Are JCA and the EU Pharma Package Changing ... leerink.com
  13. 13 Trump's drug pricing policy could delay new medicines in Europe medwatch.com
  14. 14 How are the US MFN and German MFG likely to impact pharmaceutical companies’ launch strategies? pharmaphorum.com
  15. 15 Innovative pharmaceutical manufacturers: new US drug pricing regulation could pose a threat to the Hungarian pharmaceutical market trademagazin.hu
  16. 16 WSJ: EU Learns Hard Old Lesson on Price Controls hotair.com
  17. 17 Trump's drug policy linked to fewer launches in Europe www.lifesciencefocus.com
  18. 18 The Trump administration’s international drug-price policy hasn’t appeared to temper the price of new drugs ... article.wn.com
  19. 19 Trump’s Plan to Lower Drug Prices in U.S. Is Leading to Fewer New Drugs in Europe finance.yahoo.com
  20. 20 Trumps läkemedelspolitik kopplas till färre lanseringar i Europa - WSJ www.placera.se
  21. 21 Five things for pharma marketers to know for Wednesday, November 11, 2026 www.mmm-online.com
Etiketler
Share

Related Posts